UNAIDS. Global HIV and AIDS statistics - Fact sheet 2021. https://www.unaids.org/en/resources/fact-sheet. Accessed 04 Feb 2022
UNAIDS. Country progress report - Zambia. Global AIDS monitoring 2020. https://www.unaids.org/sites/default/files/country/documents/ZMB_2020_countryreport.pdf. Accessed 04 Feb 2022.
UNICEF. HIV/AIDS 2020. https://www.unicef.org/zambia/hivaids. Accessed on 21 Aug 2022
Zambia Statistics Agency, Ministry of Health (MOH) Zambia, and ICF 2019. Zambia Demographic Health Survey; 2018
Chimbwandira F, Mhango E, Makombe S, Midiani D, Mwansambo C, Njala J, et al. Impact of an innovative approach to prevent mother-to-child transmission of HIV-Malawi, July 2011-September 2012. Morb Mortal Wkly Rep. 2013;62(8):148–51.
WHO. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva: WHO; 2012.
Ministry of Health Zambia. Lifelong antiretroviral drugs for all HIV positive women in Zambia - Policy guidelines for health facilities in Zambia; 2013
Shaffer N, Abrams EJ, Becquet R. Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings: great promise but some early caution. AIDS. 2014;28(4):599–601.
Morgenstern T, Grimes D, Grimes R. Assessment of readiness to initiate antiretroviral therapy. HIV Clin Trials. 2002;3(2):168–72.
Chanda BC, Likwa RN, Zgambo J, Tembo L, Jacobs C. Acceptability of option B+ among HIV positive women receiving antenatal and postnatal care services in selected health centre’s in Lusaka. BMC Pregnancy Childbirth. 2018;18(1):510.
Article PubMed PubMed Central Google Scholar
Mubiana-Mbewe M, Bosomprah S, Kadota JL, Koyuncu A, Kusanathan T, Mweebo K, et al. Effect of enhanced adherence package on early ART uptake among HIV-positive pregnant women in Zambia: an individual randomized controlled trial. AIDS Behav. 2021;25(3):992–1000.
Buregyeya E, Naigino R, Mukose A, Makumbi F, Esiru G, Arinaitwe J, et al. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study. BMC Pregnancy Childbirth. 2017;17(1):94.
Article PubMed PubMed Central Google Scholar
Haas AD, Tenthani L, Msukwa MT, Tal K, Jahn A, Gadabu OJ, et al. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi’s option B+ programme: an observational cohort study. The lancet HIV. 2016;3(4):e175–82.
Article PubMed PubMed Central Google Scholar
Tenthani LHA, Tweya H, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘option B+’) in Malawi. AIDS. 2014;28(4):589–98.
Article CAS PubMed Google Scholar
Balfour L, Tasca GA, Kowal J, Corace K, Cooper CL, Angel JB, et al. Development and validation of the HIV medication readiness scale. Assessment. 2007;14(4):408–16.
Fernández MI, Hosek S, Warren JC, Jacobs RJ, Hernandez N, Martinez J, et al. Development of an easy to use tool to assess HIV treatment readiness in adolescent clinical care settings. AIDS Care. 2011;23(11):1492–9.
Article PubMed PubMed Central Google Scholar
Hinkin TR. A review of scale development practices in the study of organizations. J Manag. 1995;21(5):967–88.
Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Pub Health. 2018. https://doi.org/10.3389/fpubh.2018.00149.
Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26(16):2039–52.
Bangsberg DR, Liu H. A closer look at depression and its relationship to HIV antiretroviral adherence. Ann Behavl Med. 2011;42(3):352–60.
Balfour L, Kowal J, Silverman A, Tasca G, Angel J, Macpherson P, et al. A randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART. AIDS Care. 2006;18(7):830–8.
Article CAS PubMed Google Scholar
Tremblay CL, Baril J-G, Fletcher D, Kilby D, MacPherson P, Shafran SD, et al. Challenges in initiating antiretroviral therapy in 2010. Canadian J Infect Dis Med Microbiol. 2010;21(Suppl C):1C-15C.
Fehr J, Nicca D, Sendi P, Wolf E, Wagels T, Kiss A, et al. Starting or changing therapy–a prospective study exploring antiretroviral decision-making. Infection. 2005;33(4):249–56.
Article CAS PubMed Google Scholar
Wolff B, Mbonye M, Coutinho A, Amuron B, Nkabala R, Jaffar S, et al. High levels of psychosocial readiness for ART in an African population at the onset of treatment SAHARA-J. J Soc Aspects of HIV/AIDS. 2009;6(4):111.
MacDonell KE, Naar-King S, Murphy DA, Parsons JT, Harper GW. Predictors of medication adherence in high risk youth of color living with HIV. J Pediatr Psychol. 2009;35(6):593–601.
Article PubMed PubMed Central Google Scholar
Tessema B, Biadglegne F, Mulu A, Getachew A, Emmrich F, Sack U. Magnitude and determinants of nonadherence and nonreadiness to highly active antiretroviral therapy among people living with HIV/AIDS in Northwest Ethiopia: a cross-sectional study. AIDS Res Ther. 2010;7(1):2.
Article PubMed PubMed Central Google Scholar
Nunnally J, Bernstein I. Psychometric Theory. New York: McGrawHiIl Inc; 1978.
Ong DC. A Primer to Bootstrapping; and an Overview of doBootstrap. Department of Psychology; 2014
Cattell RB. The scree test for the number of factors. Multivar Behav Res. 1966;1(2):245–76.
Popham WJ, Husek TR. Implications of criterion-referenced measurement 1, 2. Journal of Educational Measurement. 1969 Mar;6(1):1-9
Raykov T, Marcoulides GA. Introduction to psychometric theory. Routledge; 2011
DeVellis RF. Scale Development: Theory and Application. Los Angeles: CA Sage Publications; 2012.
Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297–334.
Grimes RM, Grimes DE. Readiness: the state of the science (or the lack thereof). Curr HIV/AIDS Rep. 2010;7(4):245–52.
Article PubMed PubMed Central Google Scholar
Mutanga JN, Mutembo S, Ezeamama AE, Fubisha RC, Sialondwe D, Simuchembu B, et al. Tracking progress toward elimination of mother to child transmission of HIV in Zambia: findings from the early infant diagnosis of HIV program (2009–2017). J Trop Pediatr. 2020;66(1):56–65.
Mukose AD, Bastiaens H, Makumbi F, Buregyeya E, Naigino R, Musinguzi J, et al. What influences uptake and early adherence to option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in central Uganda? A mixed methods study. PLoS ONE. 2021;16(5): e0251181.
Article CAS PubMed PubMed Central Google Scholar
Mukosha M, Chiyesu G, Vwalika B. Adherence to antiretroviral therapy among HIV infected pregnant women in public health sectors: a pilot of Chilenje level one hospital Lusaka Zambia. Pan African Med J. 2020;35:111.
Hodgson I, Plummer ML, Konopka SN, Colvin CJ, Jonas E, Albertini J, et al. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS ONE. 2014;9(11): e111421.
Article PubMed PubMed Central Google Scholar
Logie CH, Lacombe-Duncan A, Wang Y, Kaida A, Conway T, Webster K, et al. Pathways from HIV-related stigma to antiretroviral therapy measures in the HIV care cascade for women living with HIV in Canada. J Acquir Immune Defic Syndr. 2018;77(2):144.
Ankomah A, Ganle JK, Lartey MY, Kwara A, Nortey PA, Okyerefo MPK, et al. ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study. BMC Infect Dis. 2016;16(1):1–12.
King R, Matovu JN, Rujumba J, Wavamunno P, Amone A, Gabagaya G, et al. PMTCT option B+ 2012 to 2018—taking stock: barriers and strategies to improve adherence to option B+ in urban and rural Uganda. Afr J AIDS Res. 2020;19(2):135–46.
Stranix-Chibanda L, Brummel S, Pilotto J, Mutambanengwe M, Chanaiwa V, Mhembere T, et al. Slow acceptance of universal antiretroviral therapy (ART) among mothers enrolled in IMPAACT PROMISE studies across the globe. AIDS Behav. 2019;23(9):2522–31.
Article CAS PubMed PubMed Central Google Scholar
Moges NA, Adesina OA, Okunlola MA, Berhane Y. Same-day antiretroviral treatment (ART) initiation and associated factors among HIV positive people in Northwest Ethiopia: baseline characteristics of prospective cohort. Archiv Pub Health. 2020;78(1):1–13.
留言 (0)